|
ID
|
Author
|
Year
|
Title
|
Publisher
|
| 4658591 |
Zgraggen, Armin; Stoffel, Sandro Tiziano; Barbier, Michaela Carla; Marbet, Urs Albert |
2022 |
Colorectal cancer surveillance by colonoscopy in a prospective, population-based long-term Swiss screening study - outcomes, adherence, and costs |
Zeitschrift für Gastroenterologie |
| 4658544 |
Barbier, Michaela C; Tomonaga, Yuki; Menges, Dominik; Yebyo, Henock G; Haile, Sarah R; Puhan, Milo A; Schwenkglenks, Matthias |
2022 |
Survival modelling and cost-effectiveness analysis of treatments for newly diagnosed metastatic hormone-sensitive prostate cancer. |
PloS one |
| 4658551 |
Menges, Dominik; Yebyo, Henock G; Sivec-Muniz, Sergio; Haile, Sarah R; Barbier, Michaela C; Tomonaga, Yuki; Schwenkglenks, Matthias; Puhan, Milo A |
2022 |
Treatments for Metastatic Hormone-sensitive Prostate Cancer: Systematic Review, Network Meta-analysis, and Benefit-harm assessment. |
European urology oncology |
| 4662165 |
Barbier, Michaela Carla; Pardo, Esther; Panje, Cédric Michael; Gautschi, Oliver; Lupatsch, Judith Eva; Swiss Group for Clinical Cancer Research (SAKK), |
2021 |
A cost-effectiveness analysis of pembrolizumab with or without chemotherapy for the treatment of patients with metastatic, non-squamous non-small cell lung cancer and high PD-L1 expression in Switzerland. |
The European journal of health economics : HEPAC : health economics in prevention and care |
| 4638642 |
Barbier, Michaela; Durno, Nicholas; Bennison, Craig; Örtli, Mathias; Knapp, Christian; Schwenkglenks, Matthias |
2021 |
Cost-effectiveness and budget impact of venetoclax in combination with rituximab in relapsed/refractory chronic lymphocytic leukemia in Switzerland |
The European journal of health economics : HEPAC : health economics in prevention and care |
| 4615134 |
Panje, C. M.; Lupatsch, J. E.; Barbier, M.; Pardo, E.; Lorez, M.; Dedes, K. J.; Aebersold, D. M.; Plasswilm, L.; Gautschi, O.; Schwenkglenks, M.; Swiss Group for Clinical Cancer Research, |
2020 |
A cost-effectiveness analysis of consolidation immunotherapy with durvalumab in stage III NSCLC responding to definitive radiochemotherapy in Switzerland |
Annals of Oncology |
| 4662169 |
Flack, J M; Calhoun, D A; Satlin, L; Barbier, M; Hilkert, R; Brunel, P |
2009 |
Efficacy and safety of initial combination therapy with amlodipine/valsartan compared with amlodipine monotherapy in black patients with stage 2 hypertension: the EX-STAND study. |
Journal of human hypertension |
| 4662173 |
Allemann, Yves; Fraile, Belen; Lambert, Michel; Barbier, Michaela; Ferber, Philippe; Izzo, Joseph L |
2008 |
Efficacy of the combination of amlodipine and valsartan in patients with hypertension uncontrolled with previous monotherapy: the Exforge in Failure after Single Therapy (EX-FAST) study. |
Journal of clinical hypertension (Greenwich, Conn.) |
| 4662171 |
Glasbrenner, Michaela; Rosenkranz, Gerd |
2006 |
A note on ethnic sensitivity studies. |
Journal of biopharmaceutical statistics |
